MedPath

Effectiveness of Amyl Nitrosum Mother tincture versus placebo in the treating Hypertensio

Phase 2
Not yet recruiting
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Registration Number
CTRI/2024/03/064071
Lead Sponsor
Dr Jyoti A Moolabharati
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Subjects on antihypertensive drugs.

2) Subjects who fulfill the diagnostic criteria. History, examination and routine investigation show no evidence of secondary causes.

3) Essential hypertension Grade 1 and Grade 2.

4) Subjects who are willing to take part in the study and sign the written in format consent.

Exclusion Criteria

1) Subjects with history or routine investigations, which suggest any evidence of a secondary cause for the hypertension.

2) High risk group (Grade 3).

3) Subjects with isolated systolic hypertension.

4) Presence of any systemic illnesses (endocrinal / cardiovascular/ locomotor/ neurological/ pyschiatry etc) that was already diagnosedor detected clinically or in routine lab investigation.

5) Pregnant and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath